Operose Advisors LLC Novo Nordisk A S Transaction History
Operose Advisors LLC
- $307 Million
- Q3 2024
A detailed history of Operose Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Operose Advisors LLC holds 2,348 shares of NVO stock, worth $206,553. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,348
Previous 2,348
-0.0%
Holding current value
$206,553
Previous $335,000
16.72%
% of portfolio
0.09%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,904Shares Held
317MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.75 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.26 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.17 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $199B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...